23 reports

  • 4. KEY INFERENCES

RENAL DISEASES ##. ##. ## RAPID TECHNOLOGICAL ADVANCES IN THE FIELD OF GENETICS Advances in the field of genetic technology during the last decade have enlightened our knowledge regarding genetic regulatory pathways related to renal biomarkers.

  • Renal Disease
  • United States
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.

Immunohematology, ##(##), ##-## < PMID> ##< / PMID>.

  • Renal Disease
  • Japan
  • United States
  • Amgen Inc.
  • Roche Group

RHEUMATOLOGY; ##(##): ##-##.

  • Renal Disease
  • France
  • Italy
  • United States
  • Forecast
  • UPDATES

“Chronic Kidney Disease (CKD) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small...

  • Renal Disease
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Proportion of Polycystic Kidney Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Proportion of Polycystic Kidney Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2016*

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016" provides an overview of Polycystic Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Drug Discovery And Development
  • Genetic Disorder
  • Renal Disease
  • World
  • Product Initiative

The molecules developed by Companies in Filing rejected/ Withdrawn, Phase I, IND/ CTA Filed and Preclinical stages are ##, ##, ## and ## respectively.

  • Renal Disease
  • United States
  • World
  • Product Initiative
  • CTI BioPharma Corp.
  • Renal Diseases, Global, Pipeline Programs Targeting Connective Tissue Growth Factor, 2017
  • Renal Diseases, Global, AKI Types, 2017

In Vivo; ##(##): ##-## Okamura DM, et al. (2011).

  • Chronic Disease
  • Renal Disease
  • World
  • Deals & Alliance
  • Galectin Therapeutics Inc.
  • Polycystic Kidney Disease - Companies Involved in Therapeutics Development
  • Polycystic Kidney Disease - Dormant Projects

The company primarily focuses on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease.

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • POLYCYSTIC KIDNEY DISEASE - DORMANT PROJECTS, H2 2017
  • DBM-43H11 - DRUG PROFILE

" This recommendation brings us one step closer to providing to patients in Europe the first-in-the-world, diseasemodifying treatment for ADPKD, a progressive and chronic genetic disease, " said Ole Vahlgren, CEO & President, Otsuka Europe.

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • MAR 21, 2017: WORLD LEADING PREDICTIVE DIAGNOSTIC TEST FOR DIABETIC KIDNEY DISEASE CRISIS TO ROLL-OUT IN ASIA WITH CHINA AND SINGAPORE PATENTS AND COMMERCIALISATION PARTNERS

It is a powerful alternative to genetic testing.

  • Diabetes
  • Laboratory
  • Proteomics
  • Renal Disease
  • GlobalData's company

The invention relates to genetically modified mesenchymal stem cells (MSCs) and their use as a medicament in the treatment of a tumors.

  • Diabetes
  • Renal Disease
  • United States
  • Company
  • Product Initiative

The company' s target therapeutic areas include rheumatoid arthritis, HIV/ AIDS, respiratory infections, cancer, diabetes, men' s and women' s health, and genetic conditions.

  • In Vitro Diagnostics
  • Renal Disease
  • North America
  • United States
  • Sysmex Corporation

The molecules developed by companies in Pre-Registration, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Renal Disease
  • Therapy
  • United States
  • Product Initiative
  • ChemoCentryx, Inc.

The molecules developed by companies in Phase III, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Renal Disease
  • Therapy
  • United States
  • Product Initiative
  • ChemoCentryx, Inc.

It provides research origins on cancer and inflammation therapies by utilizing the genetic information and analysis technology.

  • Chronic Disease
  • Renal Disease
  • United States
  • Company
  • Product Initiative

In the study, mice with severe hypophosphatasia, due to a genetic defect (knock-out) in one of the genes encoding for alkaline phosphatase were administered daily subcutaneous injections of recAP at doses of ##, ## or ##mg/ kg, from birth up to ## days.

  • Hospital
  • Renal Disease
  • United States
  • Product Initiative
  • Quark

THE THERAPEUTIC CANDIDATE CONSTITUTES OF DONOR-DERIVED ALLOGENEIC MESENCHYMAL STEM CELLS (MSCS) GENETICALLY ENGINEERED WITH A THERAPEUTIC TRANSGENE.

  • Diabetes
  • Renal Disease
  • United States
  • Company
  • Product Initiative

The disease in children is generally from genetic origin while adults mostly develop dRTA as a result of autoimmune disease.

  • Clinical Trial
  • Drug Discovery And Development
  • Hormone
  • Renal Disease
  • World

It provides research origins on cancer and inflammation therapies by utilizing the genetic information and analysis technology.

  • Diabetes
  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormones
  • Pharmaceutical
  • Renal Disease
  • World

Patients will be randomized (##:##:##) to receive ## mg pacritinib twice daily (BID), ## mg pacritinib once daily (QD) or best available therapy.

  • Pharmaceutical
  • Renal Disease
  • United States
  • World
  • CTI BioPharma Corp.
  • IONIS PHARMACEUTICALS, INC.

In the ##. ## mg/ kg group, one TD patient experienced worsening grade ## bone pain and one NTD patient experienced grade ## phlebitis.

  • Chronic Disease
  • Renal Disease
  • United States
  • Product Initiative
  • Bayer AG

Genetic Engineering and Biotechnology Heber Biotec S.

  • Clinical Trial
  • Drug Discovery And Development
  • Pharmaceutical
  • Renal Disease
  • World